Thyroid disorder Board decisions

The Board denied the application to reopen the claim for service connection for cancer of thyroid, also to include as a result of exposure to herbicides due to lack of new and material evidence.

The Veteran's claim for compensation under 38 U.S.C.A. § 1151 is denied as the evidence does not support a finding that VA treatment in June-July 2008 caused additional disability.

The Veteran's appeal is being remanded due to the need for additional development, including obtaining updated VA and private treatment records, scheduling a VA examination, and developing his TDIU claim.

The Board found that the Veteran's service-connected gastrointestinal disorder did not cause or contribute substantially to his death from medullary carcinoma of the thyroid with metastasis.

The Veteran's claim for compensation under 38 U.S.C.A. § 1151 is denied as there is no evidence of an additional thyroid disability resulting from VA treatment.

The Board has granted service connection for thyroiditis, finding that it is etiologically related to the Veteran's active military service.

The Board has determined that the Veteran's current thyroid disorder did not begin during or was otherwise caused by his active service, and therefore denied his claim for service connection.

The Veteran's appeal is being remanded for additional development, including scheduling VA examinations and obtaining treatment records.

The Board found that the Veteran's hypothyroidism is not directly related to his active service, including exposure to Agent Orange. The claim for service connection was denied.

The Board has restored the Veteran's 100 percent rating for his thyroid disability, effective September 1, 2009, due to errors in reducing the rating.

The Veteran died from thyroid cancer, presumed to be caused by exposure to herbicides during service. The Board finds that the cause of death is not service-connected due to lack of evidence linking the cancer to military service or herbicide exposure.

The Veteran's claim for a higher initial evaluation for her right knee disability was granted. The Board also found that the Veteran has service connection for hypothyroidism, which is etiologically related to service. Service connection for left ventricular disease was denied as secondary to claimed hypothyroidism.

The Board has determined that the Veteran's hypothyroidism is productive of symptoms including cold intolerance, fatigue, weight gain, and constipation. The disability warrants a 30 percent rating since the entire period on appeal.

The Board has remanded the case for additional development, including a VA examination and readjudication of the service connection claims.

The Board found that the service-connected disabilities did not cause or contribute to the Veteran's death, as there is no evidence of a nexus between his service and the causes of his death.

The Board has determined that the Veteran's low back, neck, and bilateral knee disabilities are not related to his active service. The thyroid disability is presumed to be due to herbicide exposure but the evidence does not support a finding of direct service connection.

The Board has determined that the Veteran's death was not caused by or related to his period of service, and there is no evidence suggesting a medical relationship between heart disease and his service-connected disabilities. As such, service connection for the cause of the Veteran's death is denied.

The Veteran's claims for service connection for bilateral hearing loss and thyroid disorder are being remanded due to the need for additional development, including obtaining medical records and scheduling VA examinations.

The Board has remanded the claims for service connection for fibromyalgia, carpal tunnel syndrome, and increased ratings for hypoparathyroidism and hypothyroidism due to further development being needed.

The Veteran's claims for service connection for parathyroid cancer and prostate cancer, both alleged to be due to exposure to ionizing radiation in service, are being remanded for further development including obtaining a new dose assessment based on the Veteran's location during atmospheric testing.